{"id":533658,"date":"2021-09-02T07:04:17","date_gmt":"2021-09-02T11:04:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/"},"modified":"2021-09-02T07:04:17","modified_gmt":"2021-09-02T11:04:17","slug":"passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/","title":{"rendered":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PHILADELPHIA, Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer of Passage Bio, will participate in a virtual panel presentation, titled \u201cWhat\u2019s Next for Neurodegenerative Diseases,\u201d at the upcoming Citi 16<sup>th<\/sup> Annual BioPharma Virtual Conference, September 8-10, 2021.<\/p>\n<p>\n        <strong>Format:<\/strong> Panel <br \/><strong>Date:<\/strong> Wednesday, September 8, 2021<br \/><strong>Time:<\/strong> 11:35 a.m. ET<\/p>\n<p>A live webcast of the events will be available on the Investors &amp; Media section of Passage Bio\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ypgBceYh0aWFXdW_d_2Vmi3-cYTWjZSRz_Wi_iMjLFZSbbrRSMbhnH7ImVrjbhi6aRbVLxbl4rDmAn5U5frqpCPrWaZ9cuo5OuKNywdeeWU=\" rel=\"nofollow noopener\" target=\"_blank\">investors.passagebio.com<\/a>. A replay of the presentations will be available for 30 days following the events.<\/p>\n<p>\n        <strong>About Passage Bio <\/strong><br \/>\n        <br \/>At Passage Bio (Nasdaq: PASG), we are on a mission to provide life-transforming genetic medicines for patients with CNS diseases that replace their suffering with boundless possibility, all while building lasting relationships with the communities we serve. Based in Philadelphia, PA, our company has established a strategic collaboration and licensing agreement with the renowned University of Pennsylvania\u2019s Gene Therapy Program to conduct our discovery and IND-enabling preclinical work. This provides our team with enhanced access to a broad portfolio of gene therapy candidates and future gene therapy innovations that we then pair with our deep clinical, regulatory, manufacturing and commercial expertise to rapidly advance our robust pipeline of optimized gene therapies into clinical testing. As we work with speed and tenacity, we are always mindful of patients who may be able to benefit from our therapies. More information is available at www.passagebio.com.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p>Investors:<br \/>Stuart Henderson<br \/>Passage Bio<br \/>267.866.0114<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=irCydrNXLNhxomw8Ku7zK7ZSei778Dr6Cu4YlnRTKi4jvUaQqSwdF4pT5cpNapeJmAjSa2Tg5p3d0ACUhxQUUUrgaBA6teIC0zXv7cFPhAk=\" rel=\"nofollow noopener\" target=\"_blank\">shenderson@passagebio.com<\/a><\/p>\n<p>Media:<br \/>Gwen Fisher<br \/>Passage Bio<br \/>215.407.1548<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EdzqIESKLeI4Ux9M82zk1-Egpjb_ztozeZyYIl0nEtM-h4ZpV8yhB1yzKxOfSq7im25DBxFVAvAZKaNusUqV8aXNKAcSo5lSDPSfWrbHA6M=\" rel=\"nofollow noopener\" target=\"_blank\">gfisher@passagebio.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Mjg0YzU2MDQtMzQ0YS00ZTY5LThjZDEtN2M1NDViNTU0OTgzLTExNDgwMjg=\/tiny\/Passage-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer of Passage Bio, will participate in a virtual panel presentation, titled \u201cWhat\u2019s Next for Neurodegenerative Diseases,\u201d at the upcoming Citi 16th Annual BioPharma Virtual Conference, September 8-10, 2021. Format: Panel Date: Wednesday, September 8, 2021Time: 11:35 a.m. ET A live webcast of the events will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentations will be available for 30 days following the events. About Passage Bio At Passage Bio (Nasdaq: PASG), we &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533658","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer of Passage Bio, will participate in a virtual panel presentation, titled \u201cWhat\u2019s Next for Neurodegenerative Diseases,\u201d at the upcoming Citi 16th Annual BioPharma Virtual Conference, September 8-10, 2021. Format: Panel Date: Wednesday, September 8, 2021Time: 11:35 a.m. ET A live webcast of the events will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentations will be available for 30 days following the events. About Passage Bio At Passage Bio (Nasdaq: PASG), we &hellip; Continue reading &quot;Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:04:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference\",\"datePublished\":\"2021-09-02T11:04:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/\",\"name\":\"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\",\"datePublished\":\"2021-09-02T11:04:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk","og_description":"PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer of Passage Bio, will participate in a virtual panel presentation, titled \u201cWhat\u2019s Next for Neurodegenerative Diseases,\u201d at the upcoming Citi 16th Annual BioPharma Virtual Conference, September 8-10, 2021. Format: Panel Date: Wednesday, September 8, 2021Time: 11:35 a.m. ET A live webcast of the events will be available on the Investors &amp; Media section of Passage Bio\u2019s website at investors.passagebio.com. A replay of the presentations will be available for 30 days following the events. About Passage Bio At Passage Bio (Nasdaq: PASG), we &hellip; Continue reading \"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:04:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference","datePublished":"2021-09-02T11:04:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/","name":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=","datePublished":"2021-09-02T11:04:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTkzMSM0Mzc3MjMwIzIxMzY0NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/passage-bio-to-present-at-citi-16th-annual-biopharma-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533658"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533658\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}